Assessment of Efficacy and Toxicity of Cyclophosphamide Chemotherapy in Canines with Malignant Mammary Tumor: A Retrospective Study

Table 2

Mean ± SE values of clinical/physiological parameters in dogs with malignant mammary tumor prior treatment in both the groups at periodical intervals.

Treatment group	Clinical parameter	0^th (day)	1^st (day)	3^rd (day)	7^th (day)	14^th (day)	21^st (day)
I	Body temperature (°C)	38.12 ± 1.092	37.00 ± 1.000	37.84 ± 1.014	38.12 ± 6.310	38.12 ± 4.200	37.23 ± 1.218
	Heart rate (/min)	118.00 ± 14.5	117.12 ± 10.00	119.21 ± 63.45	116.01 ± 42.10	120.11 ± 21.00	119.00 ± 32.10
	Respiratory rate (/min)	47.21 ± 15.21	50.00 ± 54.21	49.10 ± 21.01	48.21 ± 34.21	52.13 ± 10.00	49.14 ± 82.16
II	Body temperature (°C)	37.82 ± 1.082	38.14 ± 1.142	37.42 ± 2.101	39.25 ± 3.210	40.00 ± 1.092	39.56 ± 1.241
	Heart rate (/min)	120.01 ± 51.2	118.21 ± 41.22	115.63 ± 25.12	118.00 ± 10.21	117.13 ± 63.24	120.56 ± 32.10
	Respiratory rate (/min)	46.12 ± 72.16	49.24 ± 56.21	50.12 ± 32.10	52.13 ± 54.12	49.15 ± 34.23	48.24 ± 11.00